Literature DB >> 14569193

Genotyping patients with recent blood transfusions.

Michelle Ng Gong1, Yang Sai, Wei Zhou, B Taylor Thompson, Li-Lian Xu, David C Christiani.   

Abstract

BACKGROUND: Many studies have used polymerase chain reaction amplification (PCR) to genotype for common polymorphisms in intensive-care units (ICUs) where blood transfusions are common. Evidence that donor leukocytes in transfused blood can be detected by PCR of the recipient blood suggests that this minor population of donor white cells (microchimerism) can interfere with genotyping of allelic polymorphisms in critically ill transfused patients. To investigate this possibility, we assayed DNA extracted from the blood and buccal cells of ICU patients for 2 common polymorphisms in the TNF-beta gene and the surfactant protein-B (SP-B) gene.
METHODS: Study subjects were ICU patients from the Massachusetts General Hospital (Boston, MA) enrolled into a study on the molecular epidemiology of acute respiratory distress syndrome between January 1999 and October 2000. Blood and buccal cells were collected and DNA was extracted from 145 patients. Genotyping was performed by enzyme digestion and pyrosequencing.
RESULTS: The Kappa statistics comparing the genotype results from blood and buccal cells were 0.98 (95% confidence interval [CI] = 0.94-1.01) for TNFB and 0.95 (CI = 0.87-1.02) for SP-B. When the analysis was restricted only to the 107 patients who were transfused, the Kappa statistic remained high at 0.97 (CI = 0.93-1.01) for TNFB and 0.93 (CI = 0.84-1.03) for SP-B.
CONCLUSION: We conclude that microchimerism from allogeneic blood transfusion is unlikely to have major effects on the genotype results of common polymorphisms in large molecular epidemiology studies conducted in the critical care setting if DNA is collected within a day after transfusions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14569193      PMCID: PMC1913491          DOI: 10.1097/01.ede.0000091680.23304.21

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  22 in total

1.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  Detection of circulating donor white blood cells in patients receiving multiple transfusions.

Authors:  P T Adams; R D Davenport; D A Reardon; M S Roth
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

Review 3.  Leukocyte reduction in blood component therapy.

Authors:  T A Lane; K C Anderson; L T Goodnough; S Kurtz; G Moroff; P T Pisciotto; M Sayers; L E Silberstein
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

4.  A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis.

Authors:  F Stüber; M Petersen; F Bokelmann; U Schade
Journal:  Crit Care Med       Date:  1996-03       Impact factor: 7.598

5.  Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation.

Authors:  T H Lee; E Donegan; S Slichter; M P Busch
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

6.  Detection of microchimerism after allogeneic blood transfusion using nested polymerase chain reaction amplification with sequence-specific primers (PCR-SSP): a cautionary tale.

Authors:  A S Carter; M Bunce; L Cerundolo; K I Welsh; P J Morris; S V Fuggle
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

7.  Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome.

Authors:  J Floros; S V Veletza; P Kotikalapudi; L Krizkova; A M Karinch; C Friedman; S Buchter; K Marks
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

8.  Circulation of donor lymphocytes after blood transfusion in man.

Authors:  G P Schechter; J Whang-Peng; W McFarland
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

9.  Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome.

Authors:  Clare L Reid; Chris Perrey; Vera Pravica; Ian V Hutchinson; Iain T Campbell
Journal:  Crit Care Med       Date:  2002-10       Impact factor: 7.598

10.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.

Authors:  G Messer; U Spengler; M C Jung; G Honold; K Blömer; G R Pape; G Riethmüller; E H Weiss
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  3 in total

1.  Can post-mortem blood be used for DNA profiling after peri-mortem blood transfusion?

Authors:  E A M Graham; M Tsokos; G N Rutty
Journal:  Int J Legal Med       Date:  2005-12-10       Impact factor: 2.686

2.  Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.

Authors:  Kiichi Nakahira; Sun-Young Kyung; Angela J Rogers; Lee Gazourian; Sojung Youn; Anthony F Massaro; Carolina Quintana; Juan C Osorio; Zhaoxi Wang; Yang Zhao; Laurie A Lawler; Jason D Christie; Nuala J Meyer; Finnian R Mc Causland; Sushrut S Waikar; Aaron B Waxman; Raymond T Chung; Raphael Bueno; Ivan O Rosas; Laura E Fredenburgh; Rebecca M Baron; David C Christiani; Gary M Hunninghake; Augustine M K Choi
Journal:  PLoS Med       Date:  2013-12-31       Impact factor: 11.069

Review 3.  Matrix and backstage: cellular substrates for viral vaccines.

Authors:  Ingo Jordan; Volker Sandig
Journal:  Viruses       Date:  2014-04-11       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.